XML 21 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
Selected Quarterly Financial Data (Unaudited) (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Selected Quarterly Financial Data (Unaudited)                      
Net sales $ 6,897,000 $ 7,242,000 $ 6,936,000 $ 6,506,000 $ 5,986,000 $ 6,706,000 $ 5,989,000 $ 5,950,000 $ 27,581,000 $ 24,631,000 $ 16,827,000
Gross profit 2,707,000 2,865,000 2,812,000 2,574,000 2,053,000 2,827,000 2,790,000 2,104,000 10,958,000 9,774,000 6,341,000
Net income 2,633,000 607,000 476,000 493,000 1,158,000 1,113,000 875,000 486,000 4,209,000 3,632,000 1,730,000
Net income per share-                      
Basic (in dollars per share) $ 0.48 $ 0.11 $ 0.09 $ 0.09 $ 0.21 $ 0.21 $ 0.16 $ 0.09 $ 0.77 $ 0.67 $ 0.32
Diluted (in dollars per share) $ 0.47 $ 0.11 $ 0.08 $ 0.08 $ 0.20 $ 0.20 $ 0.16 $ 0.09 $ 0.74 $ 0.66 $ 0.32
Additional disclosure                      
Abnormal production costs 282,000 161,000 481,000 233,000 575,000 236,000 218,000 198,000 1,157,000 1,174,000 439,000
Income tax benefit due to reduction in valuation allowance of deferred tax assets $ 1,912,000       $ 892,000       $ 1,912,000 $ 892,000 $ 552,000